France· FR:65925723
BILASKA 20 mg, comprimé
A medicinal product containing bilastine, registered in France by MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BILASTINE
- Manufacturer
- MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400949913589plaquette(s) polyamide aluminium PVC acétate de polyvinyle de 10 comprimé(s)EUR 1.45
- cip133400949913701plaquette(s) polyamide aluminium PVC acétate de polyvinyle de 30 comprimé(s)EUR 3.69
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bilastine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaABISAXGlenmark Pharmaceuticals s.r.o., Praha
- SpainABISAX 20 MG COMPRIMIDOS EFGGlenmark Arzneimittel Gmbh
- PolandAdablixAdamed Pharma S.A.
- SwitzerlandAllerxtin Sandoz 20 mg, TablettenSandoz Pharmaceuticals AG
- SwedenBilacina 20 mg Munsönderfallande tablettLaboratorios Cinfa S.A.
- CanadaAPO-BILASTINE TABLETSAPOTEX INC
- IrelandBilhista 20 mg tabletsAlfred E Tiefenbacher (GmbH & Co. KG)
- United KingdomBilastine 20mg tabletsMilpharm Ltd
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Bilastin Hyperpoll, Bilastin Tiefenbacher
- Belgium · Bellozal, Bilastine Ab
- Bulgaria · Bilastine Stada, Биластин Мсн
- Cyprus · Alivixa, Bilastine Delorbis
- Czechia · Abisax, Bilastin Stada
- Germany · Allegra Allergietabletten, Allegra Allergietabletten Kinder
- Denmark · Bilastine Stada, Revitelle
- Estonia · Bilastin, Bilastine Stada
- Spain · Abisax, Abrilia
- Finland · Bilastine Stada, Revitelle
- United Kingdom (Northern Ireland) · Bilastine Medreich, Bilastine Milpharm
- Greece · Bilargen, Bilastine Stada
- Croatia · Actine, Nixar
- Hungary · Bilastine Supremex, Bilastine Teva
- Ireland · Bilastine Clonmel, Bilhista
- Iceland · Bilaxten
- Italy · Alyne, Ayrinal
- Lithuania · Belargan, Bilastine Sandoz
- Luxembourg · Bellozal, Bilastine Eurogenerics
- Latvia · Bilastine Stada, Bilpexo
- Malta · Alivixa, Bilastine Clonmel
- Norway · Bilastine Stada, Zilas
- Poland · Adablix, Allertec Effect
- Portugal · Aelardis, Alostine
- Romania · Bilastină Gemax Pharma, Bilastină Msn
- Sweden · Bilacina, Bilastin Teva
- Slovenia · Bilador, Bilastin Stada
- Slovakia · Abisax, Bilastin Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2ca74d52-c4a9-4fe5-85b8-2760711a22d2 GET /v1/drugs/2ca74d52-c4a9-4fe5-85b8-2760711a22d2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65925723",
"date_amm": "2011-04-01",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "BILASTINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about bilastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.